MRC Centre for Outbreak Analysis and Modelling, Department of Infectious Disease Epidemiology, Faculty of Medicine, Imperial College London, Norfolk Place, London W2 1PG, UK.
Department of Immunology and Infection, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT, UK.
Nature. 2015 Dec 3;528(7580):S53-9. doi: 10.1038/nature16043.
It is estimated that pneumonia is responsible for 15% of childhood deaths worldwide. Recent research has shown that hypoxia and malnutrition are strong predictors of mortality in children hospitalized for pneumonia. It is estimated that 15% of children under 5 who are hospitalized for pneumonia have hypoxaemia and that around 1.5 million children with severe pneumonia require oxygen treatment each year. We developed a deterministic compartmental model that links the care pathway to disease progression to assess the impact of introducing pulse oximetry as a prognostic tool to distinguish severe from non-severe pneumonia in under-5 year olds across 15 countries with the highest burden worldwide. We estimate that, assuming access to supplemental oxygen, pulse oximetry has the potential to avert up to 148,000 deaths if implemented across the 15 countries. By contrast, integrated management of childhood illness alone has a relatively small impact on mortality owing to its low sensitivity. Pulse oximetry can significantly increase the incidence of correctly treated severe cases as well as reduce the incidence of incorrect treatment with antibiotics. We also found that the combination of pulse oximetry with integrated management of childhood illness is highly cost-effective, with median estimates ranging from US$2.97 to $52.92 per disability-adjusted life year averted in the 15 countries analysed. This combination of substantial burden reduction and favourable cost-effectiveness makes pulse oximetry a promising candidate for improving the prognosis for children with pneumonia in resource-poor settings.
据估计,肺炎占全球儿童死亡人数的 15%。最近的研究表明,缺氧和营养不良是儿童因肺炎住院死亡的强有力预测因素。据估计,在因肺炎住院的 5 岁以下儿童中,有 15%存在低氧血症,每年约有 150 万患有严重肺炎的儿童需要接受氧疗。我们开发了一种确定性的隔室模型,将护理途径与疾病进展联系起来,以评估在全球负担最重的 15 个国家中,引入脉搏血氧仪作为一种预测工具来区分 5 岁以下儿童严重和非严重肺炎的影响。我们估计,如果在这 15 个国家实施,脉搏血氧仪有可能避免多达 14.8 万人死亡,假设可以获得补充氧气。相比之下,由于其敏感性较低,儿童疾病综合管理对死亡率的影响相对较小。脉搏血氧仪可以显著增加正确治疗严重病例的比例,并减少抗生素治疗不当的比例。我们还发现,脉搏血氧仪与儿童疾病综合管理相结合具有很高的成本效益,在分析的 15 个国家中,每避免一个残疾调整生命年的中位数估计值范围为 2.97 美元至 52.92 美元。这种在减少负担和提高成本效益方面的显著结合,使脉搏血氧仪成为改善资源匮乏环境中肺炎患儿预后的一个有前途的候选方案。